Oscar Health, Inc. (OSCR) Reports Q3 Loss, Lags Revenue Estimates

Core Insights - Oscar Health, Inc. reported a quarterly loss of $0.53 per share, which was better than the Zacks Consensus Estimate of a loss of $0.55, but worse than a loss of $0.22 per share a year ago, indicating an earnings surprise of +3.64% [1] - The company generated revenues of $2.99 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 3.37%, compared to $2.42 billion in the same quarter last year [2] - Oscar Health shares have increased by approximately 26.7% year-to-date, outperforming the S&P 500's gain of 15.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.87 on revenues of $3.06 billion, and for the current fiscal year, it is -$1.42 on revenues of $12.06 billion [7] - The estimate revisions trend for Oscar Health was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Industry Context - The Insurance - Multi line industry, to which Oscar Health belongs, is currently ranked in the top 27% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]